Considerations in the development of circulating tumor cell technology for clinical use
about
"Sentinel" circulating tumor cells allow early diagnosis of lung cancer in patients with chronic obstructive pulmonary diseaseMutational Analysis of Circulating Tumor Cells Using a Novel Microfluidic Collection Device and qPCR AssayCirculating tumor cells in breast cancerImproving pancreatic cancer diagnosis using circulating tumor cells: prospects for staging and single-cell analysisMetastasis of circulating tumor cells: favorable soil or suitable biomechanics, or both?Micrometastatic cancer cells in lymph nodes, bone marrow, and blood: Clinical significance and biologic implicationsCirculating Plasma MicroRNAs As Diagnostic Markers for NSCLCValidation of biomarkers to predict response to immunotherapy in cancer: Volume I - pre-analytical and analytical validationCirculating tumor cells versus circulating tumor DNA in lung cancer-which one will win?Are morphological criteria sufficient for the identification of circulating tumor cells in renal cancer?Detecting circulating tumor material and digital pathology imaging during pancreatic cancer progression.KRAS genotypic changes of circulating tumor cells during treatment of patients with metastatic colorectal cancer.Characterization of microfluidic shear-dependent epithelial cell adhesion molecule immunocapture and enrichment of pancreatic cancer cells from blood cells with dielectrophoresis.NanoVelcro Chip for CTC enumeration in prostate cancer patients.Detection and preliminary evaluation of circulating tumor cells in the peripheral blood of patients with eight types of cancer using a telomerase-specific adenovirus.Bone marrow as a reservoir for disseminated tumor cells: a special source for liquid biopsy in cancer patientsQuantitative characterization of androgen receptor protein expression and cellular localization in circulating tumor cells from patients with metastatic castration-resistant prostate cancer.Retaining the long-survive capacity of Circulating Tumor Cells (CTCs) followed by xeno-transplantation: not only from metastatic cancer of the breast but also of prostate cancer patients.Method validation of circulating tumour cell enumeration at low cell counts.Circulating tumor cells as early predictors of metastatic spread in breast cancer patients with limited metastatic dissemination.The development of surface-enhanced Raman scattering as a detection modality for portable in vitro diagnostics: progress and challenges.Epithelial-mesenchymal transitioned circulating tumor cells capture for detecting tumor progressionStabilization of circulating tumor cells in blood using a collection device with a preservative reagent.Do circulating tumor cells, exosomes, and circulating tumor nucleic acids have clinical utility? A report of the association for molecular pathologyCirculating tumor cell biomarker panel as an individual-level surrogate for survival in metastatic castration-resistant prostate cancerHigh-recovery visual identification and single-cell retrieval of circulating tumor cells for genomic analysis using a dual-technology platform integrated with automated immunofluorescence staining.Optimisation of immunofluorescence methods to determine MCT1 and MCT4 expression in circulating tumour cellsCategorical versus continuous circulating tumor cell enumeration as early surrogate marker for therapy response and prognosis during docetaxel therapy in metastatic prostate cancer patientsInterrelationships of circulating tumor cells with metastasis and thrombosis: role of microRNAsClassification of blood cells and tumor cells using label-free ultrasound and photoacoustics.Optimization and Evaluation of a Novel Size Based Circulating Tumor Cell Isolation System.In vivo tibial compression decreases osteolysis and tumor formation in a human metastatic breast cancer model.Biomarker development in the context of urologic cancersIn vitro detection of circulating tumor cells compared by the CytoTrack and CellSearch methods.In patients with metastatic breast cancer the identification of circulating tumor cells in epithelial-to-mesenchymal transition is associated with a poor prognosis.Enzymatic cleavage of uracil-containing single-stranded DNA linkers for the efficient release of affinity-selected circulating tumor cellsDetection of circulating tumor cells using manually performed immunocytochemistry (MICC) does not correlate with outcome in patients with early breast cancer - Results of the German SUCCESS-A- trialCharacterization of a hybrid dielectrophoresis and immunocapture microfluidic system for cancer cell capture.Comparison and optimization of machine learning methods for automated classification of circulating tumor cells.Technical Insights into Highly Sensitive Isolation and Molecular Characterization of Fixed and Live Circulating Tumor Cells for Early Detection of Tumor Invasion.
P2860
Q21131903-51EC017C-EAA2-47C7-8FA1-D5BC8A737296Q24608051-090C2364-21CB-41A9-BBC5-0D32920BA7FFQ26774808-AE5634AE-6FCA-4828-B269-2A1D9F18C122Q26782719-419C4D1C-D014-4BBE-8871-FF13D30037FAQ26796595-BDA1B6E5-2114-4FB6-9360-CBB0655D4F1BQ26996059-D2AB9C8E-9EF2-4DF5-B569-050EA8CBA290Q28073562-6571C1B9-2143-42D5-AD13-6C21521B97C8Q28075719-FFCA7FF0-F23E-4795-AE3F-6CF15CCE7AFFQ28077340-786C17EF-205F-4D3F-BA23-9591A1189A5EQ30558415-6B8CBB0A-D6B5-4388-A24A-F2CB85F74834Q33803923-142BDDE1-3DAC-4F09-B48E-8322CC9F1E0AQ34066371-023739D6-6EEE-4181-98E4-CB465CB0FFF2Q34304356-344575DC-7507-4A4B-A3C8-1EC28849A4B8Q34354738-E9D0E278-CC92-44C1-8187-64CB74B094CFQ34372150-4C666470-8BDA-47FE-A4D6-0AF0772F97DCQ34547042-7A008A63-8491-4934-9970-EA47E2E636CDQ34611922-1BF393C0-4420-4C3A-AE38-70F52474C319Q34971918-693B7D6A-5F14-4C62-BBD9-65F44180C64DQ34984977-8D391BB8-3696-4FD6-9F53-5B23F20D41A2Q35000278-3A112656-210F-492E-A33F-DEEE79B50CCCQ35029838-2A2A72A9-3D04-4F42-B568-5CD1C5011DB4Q35102335-69CF2DBA-62D7-4ED4-AFDD-49B435A63B9BQ35112470-42608FAE-E9AE-483A-87A3-3C9A17C26C7AQ35543094-BF6D1FF6-212F-426D-8B15-EA86D018829EQ35584698-AFB8C48F-3E43-4C57-8188-E1BF2D29098BQ35604245-BFB709B0-13D5-48A7-BB5B-248694B92AF4Q35626055-F85448A2-D473-4D56-B706-AE57746B1B5EQ35655761-69F1B199-76EE-4706-AE34-29897A7CCCC4Q35664886-788DF41E-9986-4839-BEAB-55D052454A40Q35664984-6CA8F8CA-3EB4-4F7F-B743-31FCD27DD0BEQ35784738-94FFD18C-EF2B-4E5F-B06E-55015417AE53Q35838380-5046CD8E-2481-413C-BD36-2F73D248E9C8Q35906352-54506E54-4C6D-484C-93E6-F49F2FBA9858Q35929366-12008E93-50CB-474D-8298-BF46F6BD298EQ35951699-D3C61A0C-B2C3-4E32-8D97-174EA8F22AD2Q36002894-FF744FBA-7DB1-4195-9292-73448FA8EC2EQ36069885-666DB41F-C54D-4D82-B3A2-E0D75A657DC9Q36093582-D2188034-312C-4F9A-BC01-A55785FF4266Q36165928-83449D32-AF60-4C92-AE75-2295F475A95EQ36242936-721D51DB-8241-4C68-91D3-E82EA30A9A80
P2860
Considerations in the development of circulating tumor cell technology for clinical use
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh
2012年學術文章
@zh-hant
name
Considerations in the development of circulating tumor cell technology for clinical use
@ast
Considerations in the development of circulating tumor cell technology for clinical use
@en
type
label
Considerations in the development of circulating tumor cell technology for clinical use
@ast
Considerations in the development of circulating tumor cell technology for clinical use
@en
prefLabel
Considerations in the development of circulating tumor cell technology for clinical use
@ast
Considerations in the development of circulating tumor cell technology for clinical use
@en
P2093
P2860
P356
P1476
Considerations in the development of circulating tumor cell technology for clinical use
@en
P2093
Albert Deisseroth
Andrew E Schade
Brenda Gumbs Petty
Caroline C Sigman
Carolyn Compton
Daniel F Hayes
David R Parkinson
Elizabeth A Punnoose
Gary J Kelloff
Gordon Kapke
P2860
P2888
P356
10.1186/1479-5876-10-138
P577
2012-07-02T00:00:00Z
P5875
P6179
1032001576